2022
DOI: 10.1007/s11596-021-2480-5
|View full text |Cite
|
Sign up to set email alerts
|

Molecular Epidemiology and Risk Factors of Carbapenem-Resistant Klebsiella Pneumoniae Bloodstream Infections in Wuhan, China

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 29 publications
0
2
0
Order By: Relevance
“…Multidrug-resistant bacteria (MDR) infections, featuring high incidence and fatality rates, are a threat to public health ( Liu et al, 2020 ; Yu et al, 2020 ; Mei et al, 2021 ). Among them, carbapenem-resistant Klebsiella pneumoniae (CRKP) has been listed as one of the most critical drug-resistant pathogens by the World Health Organization, because its carbapenemases product, capable of hydrolyzing and inactivating carbapenems and β-lactams antibiotics, can result in the dramatical infection occlusion in bloodstream, urinary tract, surgical-site, and lung ( Broberg et al, 2014 ; Escolà-Vergé et al, 2020 ; Mehrbakhsh et al, 2020 ; Han et al, 2022 ; Liu et al, 2022 ). To treat the bacterial infections, extensive efforts have been devoted and remarkable progresses have been made using various antibiotics ( Ji et al, 2021 ; Zong et al, 2022 ).…”
Section: Introductionmentioning
confidence: 99%
“…Multidrug-resistant bacteria (MDR) infections, featuring high incidence and fatality rates, are a threat to public health ( Liu et al, 2020 ; Yu et al, 2020 ; Mei et al, 2021 ). Among them, carbapenem-resistant Klebsiella pneumoniae (CRKP) has been listed as one of the most critical drug-resistant pathogens by the World Health Organization, because its carbapenemases product, capable of hydrolyzing and inactivating carbapenems and β-lactams antibiotics, can result in the dramatical infection occlusion in bloodstream, urinary tract, surgical-site, and lung ( Broberg et al, 2014 ; Escolà-Vergé et al, 2020 ; Mehrbakhsh et al, 2020 ; Han et al, 2022 ; Liu et al, 2022 ). To treat the bacterial infections, extensive efforts have been devoted and remarkable progresses have been made using various antibiotics ( Ji et al, 2021 ; Zong et al, 2022 ).…”
Section: Introductionmentioning
confidence: 99%
“…Klebsiella pneumoniae is a gram-negative, nonmotile, encapsulated opportunistic pathogen that generally colonises human mucous membranes, including the nasopharynx and gastrointestinal tract and is ubiquitously found in soils and the healthcare environment such as on the surfaces of medical devices [ 1 , 2 ]. In immunocompromised patients, infants and older adults, it can cause a variety of infectious diseases, including lower respiratory tract infections, urinary tract infections, bacteraemia and sepsis, and can even lead to infection-related death [ 3 5 ]. Furthermore, infection caused by drug-resistant K. pneumoniae , especially by carbapenem-resistant K. pneumoniae (CRKP), are known to be associated with longer hospital stays, higher medical costs and a higher risk of mortalities than those caused by carbapenem-susceptible K. pneumoniae [ 6 ].…”
Section: Introductionmentioning
confidence: 99%